Leading science, pioneering therapies
CRM Publications

Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.

TitleMutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.
Publication TypeJournal Article
Year of Publication2012
AuthorsBilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan G, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park I-H, Friedman BA, Daley GQ, Wyllie DJA, Hardingham GE, Wilmut I, Finkbeiner S, Maniatis T, Shaw CE, Chandran S
JournalProc Natl Acad Sci U S A
Volume109
Issue15
Pagination5803-8
Date Published2012 Apr 10
ISSN1091-6490
KeywordsAdult, Cell Differentiation, Detergents, DNA-Binding Proteins, Female, Fibroblasts, Humans, Induced Pluripotent Stem Cells, Male, Middle Aged, Motor Neurons, Mutation, Organ Specificity, Solubility, TDP-43 Proteinopathies
Abstract

Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.

DOI10.1073/pnas.1202922109
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID22451909
PubMed Central IDPMC3326463
Grant List089701 / / Wellcome Trust / United Kingdom
G0300329 / / Medical Research Council / United Kingdom
G0500289 / / Medical Research Council / United Kingdom
G0900688 / / Medical Research Council / United Kingdom
G0902044 / / Medical Research Council / United Kingdom
G0902044(94018) / / Medical Research Council / United Kingdom
K08 NS072233 / NS / NINDS NIH HHS / United States
MC_G1000733 / / Medical Research Council / United Kingdom
R01 NS039074 / NS / NINDS NIH HHS / United States
/ / Biotechnology and Biological Sciences Research Council / United Kingdom
/ / Medical Research Council / United Kingdom
/ / Wellcome Trust / United Kingdom